Tech Company Financing Transactions
NeuroNOS Funding Round
NeuroNOS, based in Boston, secured $2 million from private investors.
Transaction Overview
Company Name
Announced On
3/25/2025
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the preclinical development of its small-molecule drug, designed as an injectable or oral treatment for children with autism.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
NeuroNOS: Developing innovative therapies for individuals with Central Nervous System disorders including Autism Spectrum Disorder
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amir Avniel
Browse more venture capital transactions:
Prev: 3/25/2025: Lumber venture capital transaction
Next: 3/25/2025: Arlo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs